Protocols for clinical-scale expansion of cord blood hematopoietic progenitor cells

by Alexey Bersenev on August 18, 2011 · 1 comment

in cord blood, hematopoietic, protocols

Post to Twitter Send Gmail Post to LinkedIn

Three recent articles provide different approaches for expansion of cord blood hematopoietic progenitor and stem cells. All protocols available in open access.

1. Clinical-scale cultures of cord blood CD34+ cells to amplify committed progenitors and maintain stem cell activity

Serum-free culture with bunch of cytokines. Expansion rate: total MNC ~350 fold, CD34+ ~100 fold, CFC ~130 fold. In vivo test in serial transplant. No hematopoietic stem cells (HSC) expansion confirmed in vivo, but maintenance.

2. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood

Mesenchymal stem cells for niche mimicking were used. Expansion rate: total MNC ~125 fold, CD34+ ~43 fold. In vivo transplantation assay were not done properly, but indicate to increased hematopoietic recovery in “expanded cells” group.

3. Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ−/− (NSG) mice

Serum-free culture with cytokines including Angptl5 and IGFBP2. Expansion rate in vivo: CD133+/CD34+ ~21 fold, in vivo: CD133+/CD34+ ~20 fold in SCID-repopulation activity. Very well done in vivo transplantation assays. This study is highly recommended to read!

{ 1 comment… read it below or add one }

armita August 2, 2015 at 1:21 pm

would you please answer to my question,how long it takes cord blood cell growth,when we are separate cells.

thanks for your helpfull


Leave a Comment

Previous post:

Next post: